Companies / TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.

Nasdaq: TLSICIK 1826667WESTMINSTER, CO

Financials · FY2025

Revenue$45.15M
Net income$-39.23M
Total debt$33.06M
Cash$46.29M
Diluted EPS$-1.84
Shares outstanding61.6M

Ownership

61.6M shares outstanding · as of Aug 4, 2026
7.2%Insiders
Ownership
Insiders7.16%4,410,003
Institutions22.65%13,945,532
Public float70.19%43,219,065

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Matlin David JDirector
2.15%1,323,210
Stansky Michael PDirector
1.60%986,830
Szela Mary TCEOCEO and President · Director
1.22%752,987
Hicks Kerry RDirector
0.88%542,790
Patience DavidChief Financial Officer
0.44%268,657
Cox Bryan F.Chief of Research
0.27%163,415
Stevens JenniferChief Regulatory Officer
0.20%124,110
Marshak RichardChief Commercial Officer
0.18%110,397
Devlin JodiChief of Clinical Operations
0.16%97,364
Valle WilliamDirector
0.05%30,487

Institutional holders 71

View all →
HolderValue% of shares
Nantahala Capital Management, LLC$14.45M3.36%
BlackRock, Inc.$12.10M4.32%
Vanguard Group Inc$10.68M2.49%
AWM Investment Company, Inc.$8.68M2.02%
Gilder Gagnon Howe & Co LLC$6.83M1.59%
Wealthcare Advisory Partners LLC$4.49M1.05%
Geode Capital Management, LLC$3.11M1.26%
Alyeska Investment Group, L.P.$2.84M0.66%
State Street Corporation$2.78M0.99%
Morgan Stanley$2.55M0.59%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 23, 2026Stansky Michael P
Director
BuyCommon Stock$1000.0K+244K
+44.90%
787,132
1.28% of shares
high
Feb 23, 2026Stansky Michael P
Director
BuyCommon Stock$480.5K+117K
+142.06%
199,698
0.32% of shares
high
Feb 23, 2026Valle William
Director
BuyCommon Stock$125.0K+30K
30,487
0.05% of shares
medium
Feb 23, 2026Szela Mary T
CEO
BuyCommon Stock$125.0K+30K
+4.10%
773,289
1.26% of shares
medium
Mar 17, 2026Szela Mary T
CEO
SellCommon Stock$61.4K-16K
-2.07%
752,987
1.22% of shares
low
Feb 23, 2026Gordon Gary B.
Director
BuyCommon Stock$40.0K+10K
9,756
0.02% of shares
low
Mar 11, 2026Szela Mary T
CEO
SellCommon Stock$18.0K-4K
-0.56%
768,931
1.25% of shares
low
Feb 23, 2026Patience David
Executive
BuyCommon Stock$15.0K+4K
+1.38%
268,657
0.44% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
James J. PallottaPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TLSI——89680M101—